虚拟现实手术规划用于头颈部肿瘤切除的随机初步试验
一项随机对照初步试验评估虚拟现实病例增强方案(VRCEP)用于头颈癌手术规划的可行性及对手术结局的影响,共34例患者(VRCEP组17例、标准治疗组17例)纳入最终分析,VRCEP完成率94.4%(17/18)。VRCEP组平均边缘事件评分(0.27 vs 0.94,p=0.014)和边缘事件率(11.6% vs 35.6%,p=0.0041)更低,缺损驱动边缘率也更低(10% vs 53.3%,p=0.032),外科医生任务负荷无变化。
要点
- VRCEP用于头颈癌手术规划可行,完成率94.4%(17/18),未增加外科医生任务负荷。
- VRCEP组平均边缘事件评分0.27 vs 标准治疗组0.94(p=0.014),边缘事件率11.6% vs 35.6%(p=0.0041)。
- VRCEP组缺损驱动边缘率10% vs 标准治疗组53.3%(p=0.032),切缘冰冻和最终阳性率虽更低但未达统计学显著。
核心结论
- VRCEP完成可行且未显著增加外科医生任务负荷,VRCEP组边缘事件更少。
- 作者认为需要进一步研究VR在头颈癌切除中的获益。
- 边缘事件可能是有用于评估新型手术技术的指标。
研究设计与样本
- 随机对照试验,比较VR病例增强方案(VRCEP)与标准治疗(SOC)手术规划。
- 最终分析纳入34例患者(VRCEP组17例,SOC组17例),VRCEP可评估病例完成率94.4%(17/18)。
- 主要终点为可行性,定义为>80%的VRCEP成功完成。
主要发现
- 外科医生任务负荷(TLB)采用NASA任务负荷指数评估,VRCEP组无变化。
- VRCEP组平均边缘事件评分0.27 vs SOC组0.94(p=0.014)。
- VRCEP组边缘事件率11.6% vs SOC组35.6%(p=0.0041)。
- VRCEP组缺损驱动边缘率10% vs SOC组53.3%(p=0.032)。
- 切缘冰冻阳性和最终阳性率在VRCEP组更低,但未达统计学显著。
关键数值与推荐
- 可行性定义为>80%的VRCEP成功完成,实际完成率94.4%(17/18)。
- 边缘事件定义为需要缺损驱动边缘、冰冻切缘阳性和/或最终切缘阳性。
- 边缘事件评分(MES)按每例计算,边缘事件率(MER)按每队列计算。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Application of virtual reality (VR) for surgical planning may improve clinical outcomes for head and neck cancer (HNC) resection. There is a lack of randomized trials and meaningful metrics to assess such technological applications. Our objective was to evaluate the feasibility of a VR protocol for oncologic surgical planning and assess the impact on surgical outcomes. METHODS: A randomized controlled trial utilizing a VR Case Enhancement Protocol (VRCEP) versus standard of care (SOC) surgical planning was conducted. The primary endpoint was feasibility, defined as >80% successful VRCEPs. Metrics included surgeon task-load burden (TLB) using the NASA Task-Load Index and "margin events," defined as "the need for defect-driven margins, positive frozen margins, and/or positive final margins." Margin events were used to calculate a margin event score (MES) per case and margin event rate (MER) per cohort. RESULTS: Thirty-four patients were included in the final analysis (17 VRCEP, 17 SOC) with 94.4% of eligible VRCEP cases completed (17/18). Surgeon TLB was unchanged with VRCEP. Cases undergoing VRCEP were associated with a lower mean MES (0.27 vs. 0.94, p = 0.014) and MER (11.6% vs. 35.6%, p = 0.0041). VRCEP was associated with decreased defect-driven margins (10% vs. 53.3%, p = 0.032). Although not statistically significant, positive frozen and final margin rates were lower in VRCEP. CONCLUSION: Completion of the VRCEP was feasible with no significant increase in surgeon TLB appreciated. VRCEP yielded fewer MEs. Further investigation into the benefit of VR in HNC resection is warranted. Margin events may represent useful metrics for assessing novel surgical technologies. LEVEL OF EVIDENCE: 2 Laryngoscope, 135:1090-1097, 2025.
引用
- Nunes KL, Jegede V, Mann DS, et al. A Randomized Pilot Trial of Virtual Reality Surgical Planning for Head and Neck Oncologic Resection. Laryngoscope. 2024. PMID: 39530249. doi:10.1002/lary.31874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。